NeuroVenti contributes to creating a society where we work together.
NeuroVenti strives to create a society of brain wellness.
We are NeuroVenti, Inc., an innovative biotech startup company developing small molecule drugs against
neurodevelopmental conditions, such as autism spectrum disorders(ASD) and syndromic ASD-like
fragile X syndrome. Our pipeline includes multi-target drugs which can be applied for phase II clinical trials. We also provide CDRO(Clinical
Development and Research Organization) services, including drug discovery, pre-clinical evaluation of efficacy and safety for
candidate molecules targeting CNS (neurological, psychiatric, and neurodevelopmental) disorders.
Autism spectrum disorder (ASD)
2Intractable brain disease
CNS disorders’ therapeutic candidates research service